ATE360361T1 - Kernumprogrammierung bei iswi und ähnlichen chromatinremodellierenden atpasen - Google Patents
Kernumprogrammierung bei iswi und ähnlichen chromatinremodellierenden atpasenInfo
- Publication number
- ATE360361T1 ATE360361T1 AT01975533T AT01975533T ATE360361T1 AT E360361 T1 ATE360361 T1 AT E360361T1 AT 01975533 T AT01975533 T AT 01975533T AT 01975533 T AT01975533 T AT 01975533T AT E360361 T1 ATE360361 T1 AT E360361T1
- Authority
- AT
- Austria
- Prior art keywords
- iswi
- nuclear reprogramming
- chromatin remodeling
- atpase
- similar chromatin
- Prior art date
Links
- 108010077544 Chromatin Proteins 0.000 title 1
- 101000702560 Homo sapiens Probable global transcription activator SNF2L1 Proteins 0.000 title 1
- 101000702544 Homo sapiens SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 Proteins 0.000 title 1
- 102000044753 ISWI Human genes 0.000 title 1
- 210000003483 chromatin Anatomy 0.000 title 1
- 238000007634 remodeling Methods 0.000 title 1
- 230000008672 reprogramming Effects 0.000 title 1
- 238000000034 method Methods 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 abstract 1
- 238000010367 cloning Methods 0.000 abstract 1
- 210000001082 somatic cell Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2517/00—Cells related to new breeds of animals
- C12N2517/10—Conditioning of cells for in vitro fecondation or nuclear transfer
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Developmental Biology & Embryology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23640900P | 2000-09-28 | 2000-09-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE360361T1 true ATE360361T1 (de) | 2007-05-15 |
Family
ID=22889379
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01975533T ATE360361T1 (de) | 2000-09-28 | 2001-09-28 | Kernumprogrammierung bei iswi und ähnlichen chromatinremodellierenden atpasen |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7053264B2 (de) |
| EP (1) | EP1328152B1 (de) |
| AT (1) | ATE360361T1 (de) |
| AU (2) | AU9485101A (de) |
| CA (1) | CA2423620A1 (de) |
| DE (1) | DE60128122D1 (de) |
| WO (1) | WO2002026959A2 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7491534B2 (en) * | 2000-12-22 | 2009-02-17 | Kirin Holdings Kabushiki Kaisha | Methods for altering cell fate to generate T-cells specific for an antigen of interest |
| MXPA03005624A (es) * | 2000-12-22 | 2004-12-03 | Vaurox Llc | Metodos para clonar mamiferos usando cromatina reprogramada del donador o celulas donadoras. |
| US20020142397A1 (en) | 2000-12-22 | 2002-10-03 | Philippe Collas | Methods for altering cell fate |
| EP1405068A4 (de) * | 2001-06-14 | 2007-09-26 | Infigen Inc | Verfahren zur klonierung von säugern unter verwendung von remodellierungsfaktoren |
| EP1391503A1 (de) * | 2002-08-12 | 2004-02-25 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Verfahren zur Umprogrammierung einer Zelle durch zytoplasmatichen Transfer |
| EP1678315B1 (de) | 2003-09-19 | 2011-08-03 | Sangamo BioSciences, Inc. | Gentechnisch hergestellte zinkfingerproteine zur regulation der genexpression |
| WO2015070212A1 (en) | 2013-11-11 | 2015-05-14 | Sangamo Biosciences, Inc. | Methods and compositions for treating huntington's disease |
| CN106459894B (zh) | 2014-03-18 | 2020-02-18 | 桑格摩生物科学股份有限公司 | 用于调控锌指蛋白表达的方法和组合物 |
| EP3389677B1 (de) | 2015-12-18 | 2024-06-26 | Sangamo Therapeutics, Inc. | Gezielte zerstörung des t-zell-rezeptors |
| BR112018012235A2 (pt) | 2015-12-18 | 2018-12-04 | Sangamo Therapeutics Inc | rompimento alvejado do receptor de células de mhc |
| CA3035534A1 (en) | 2016-09-07 | 2018-03-15 | Sangamo Therapeutics, Inc. | Modulation of liver genes |
| US11512287B2 (en) | 2017-06-16 | 2022-11-29 | Sangamo Therapeutics, Inc. | Targeted disruption of T cell and/or HLA receptors |
| AU2018313167A1 (en) | 2017-08-08 | 2020-02-27 | Sangamo Therapeutics, Inc. | Chimeric antigen receptor mediated cell targeting |
| TW202521561A (zh) | 2019-04-23 | 2025-06-01 | 美商聖加莫治療股份有限公司 | 染色體9開放讀框72基因表現之調節子及其用途 |
| US12152251B2 (en) | 2020-08-25 | 2024-11-26 | Kite Pharma, Inc. | T cells with improved functionality |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6011197A (en) * | 1997-03-06 | 2000-01-04 | Infigen, Inc. | Method of cloning bovines using reprogrammed non-embryonic bovine cells |
| CA2403344C (en) * | 2000-03-15 | 2013-05-21 | The University Of Georgia Research Foundation, Inc. | Effective nuclear reprogramming in mammals |
| ATE353361T1 (de) | 2000-04-28 | 2007-02-15 | Sangamo Biosciences Inc | Gezielten modifikation der chromatinstruktur |
-
2001
- 2001-09-28 WO PCT/US2001/030384 patent/WO2002026959A2/en not_active Ceased
- 2001-09-28 US US09/967,868 patent/US7053264B2/en not_active Expired - Lifetime
- 2001-09-28 DE DE60128122T patent/DE60128122D1/de not_active Expired - Lifetime
- 2001-09-28 CA CA002423620A patent/CA2423620A1/en not_active Abandoned
- 2001-09-28 AT AT01975533T patent/ATE360361T1/de not_active IP Right Cessation
- 2001-09-28 EP EP01975533A patent/EP1328152B1/de not_active Expired - Lifetime
- 2001-09-28 AU AU9485101A patent/AU9485101A/xx active Pending
- 2001-09-28 AU AU2001294851A patent/AU2001294851B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002026959A3 (en) | 2003-05-15 |
| WO2002026959A9 (en) | 2004-05-06 |
| US20020094968A1 (en) | 2002-07-18 |
| AU9485101A (en) | 2002-04-08 |
| EP1328152A2 (de) | 2003-07-23 |
| DE60128122D1 (de) | 2007-06-06 |
| US7053264B2 (en) | 2006-05-30 |
| AU2001294851B2 (en) | 2007-06-14 |
| CA2423620A1 (en) | 2002-04-04 |
| EP1328152B1 (de) | 2007-04-25 |
| WO2002026959A2 (en) | 2002-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE360361T1 (de) | Kernumprogrammierung bei iswi und ähnlichen chromatinremodellierenden atpasen | |
| EP2266396A3 (de) | Modulation von stammzellen mittels zinkfingerproteinen | |
| DK1347823T5 (da) | Fremgangsmåde og apparat til isolation af ioniske komponenter fra en væske | |
| DK1696919T3 (da) | 3-cycloalkylaminopyrrolidin-derivater som modulatorer af chemokinreceptorer | |
| ATE311363T1 (de) | Sulfohydroxamsäure and sulfohydroxamate und ihre verwendung als mek-inhibitoren | |
| WO2005047524A3 (en) | Compositions and methods for inducing cell dedifferentiation | |
| EP1058555A4 (de) | Kostimulatorische blockade und gemischter chimerismus in allotransplantationen | |
| AR102756A2 (es) | Formas polimórficas de 3-(4-amino-1-oxo-1,3-dihidro-isoindol-2-il)-piperidin-2,6-diona y composiciones que las comprenden | |
| ATE555380T1 (de) | Verfahren zur änderung des schicksals von zellen | |
| DE60144248D1 (de) | Verfahren zur klonierung von nichtmenschliche säugern unter verwendung von reprogrammiertem donorchromatin oder donorzellen | |
| ATE407138T1 (de) | Verfahren zur herstellung interferierender rna- moleküle in säugetierzellen und therapeutische anwendungen solcher moleküle | |
| DE60232234D1 (de) | Verfahren zur kultivierung von circovirus | |
| DK2258168T3 (da) | Apparat til isolering af X-kromosombærende og Y-kromosombærende populationer af spermatozoer | |
| NO20021541L (no) | 5-beta-sapogenin- og pseudosapogeninderivater samt deres anvendelse ved behandling av demens | |
| PT937074E (pt) | Benzonaftiridinas como terapeutica bronquica | |
| DK1471902T3 (da) | Sammensætninger til brug i fremgangsmåder til behandling af høretab | |
| ATE448775T1 (de) | Rifalazil zur behandlung von infektionen mit clostridium difficile | |
| DK1325011T3 (da) | Fremgangsmåder og forbindelser til behandling af proliferative sygdomme | |
| DK1321477T3 (da) | Fremgangsmåde til frembringelsen af genetisk modificerede vertebrate precursor-lymfocytter og anvendelse deraf til fremstillingen af heterologe bindende proteiner | |
| DE59712319D1 (de) | Genfallen-konstrukt zur identifizierung und isolierung von genen | |
| ATE302002T1 (de) | Verwendung von pyrazolderivaten zur behandlung von unfruchtbarkeit | |
| DE60019894D1 (de) | Phenantrhridin-n-oxides mit pde-iv hemmender wirkung | |
| ATE431396T1 (de) | Für hcv-infektion geeignete zusammensetzungen und verfahren | |
| WO2022006306A3 (en) | Compositions for genome editing and methods of use thereof | |
| DE60025327D1 (de) | 6-arylphenanthridine mit pde-iv hemmender wirkung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |